Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2019, Vol. 39 Issue (6): 25-31    DOI: 10.13523/j.cb.20190604
    
Study on β-Propiolactone in Inactivation Process of Rabies Vaccine by Gas Chromatography
Yan GAO,Jing-jing DU,Bin WANG,Qi LIU,Zhi-qiang SHEN()
Hualan Biological Engineering, INC R&D Center, Xinxiang 453000, China
Download: HTML   PDF(768KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: According to GC-FID method, the content and stability of β-propiolactone which was used as an inactivator in the preparation of rabies vaccines were systematically studied. Methods: Gas chromatography condition: Agilent DB-624 (30m×0.530mm×3.00μm)capillary column was adopted. The temperature program: Initial temperature of 80℃ was maintained for 1min, then was raised to 200℃ at the rate of 20℃/min and was maintained for 3min. Column flow: 3ml/min. The temperatures of detector and inlet were 250℃ and 150℃ respectively. The linear velocity of the carrier gas (nitrogen) was set to 25cm/s. The injection volume was 1μl and the split ratio was 2∶1. The sampling mode: Manual injection. Results: BPL showed good linear relationship in the range of 1∶100-1∶32 000 with a correlation coefficient more than 0.999. A recovery study of BPL at three different concentration (1∶200, 1∶1 000, 1∶8 000) of spiked samples with range from 95.04% to 116.86% with RSD less than 3.2% further demonstrated the reliability and feasibility of this method. Moreover, the LOD of established method can be achieved as low as 0.112μg/ml. Conclusion The method is simple, specific, stable and can be carried out at room temperature with a satisfactory result, which reduces the requirements of complicated operation. In a word, the proposed method can meet the need that determines BPL in the process of inactivating rabies virus.



Key wordsRabies vaccine      β-Propiolactone(BPL)      Gas chromatography     
Received: 25 October 2018      Published: 12 July 2019
ZTFLH:  Q819  
Corresponding Authors: Zhi-qiang SHEN     E-mail: szq3219@hualan.com
Cite this article:

Yan GAO,Jing-jing DU,Bin WANG,Qi LIU,Zhi-qiang SHEN. Study on β-Propiolactone in Inactivation Process of Rabies Vaccine by Gas Chromatography. China Biotechnology, 2019, 39(6): 25-31.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20190604     OR     https://manu60.magtech.com.cn/biotech/Y2019/V39/I6/25

Fig.1 β-propiolactone hydrolysis diagram
Fig.2 BPL recovery rates at different acetonitrile ratios
Fig.3 Gas chromatogram (a)Blank acetonitrile (b) 1∶2 000 BPL-acetonitrile standard solution (c) Sample solution with known BPL concentration
Fig.4 Standard curve of BPL Peak area A-mass concentration C
浓度梯度 回收率(%) RSD(%)
1∶200(高) 116.86 2.8
1∶1 000(中) 102.57 2.6
1∶8 000(低) 95.04 3.2
Table 1 Spiked recovery of BPL under different concentration gradients
进样次数 保留时间 峰面积
1 5.194 1 366.4
2 5.192 1 392.5
3 5.193 1 384.0
4 5.190 1 404.8
5 5.191 1 463.3
6 5.194 1 343.4
RSD(%) 0.032 2.93
Table 2 Analysis of BPL precision by gas chromatography
Fig.5 Response trend of BPL at room temperature
Fig.6 Degradation rate of BPL under different systems at 2-8℃
[1]   谭寿南, 张凤羽 . 狂犬病及人用狂犬病疫苗研究. 临床医学, 2011,24(5):2841-2843.
[1]   Tan S N, Zhang F Y . Rabies and human rabies vaccine research. Clinical Medicine, 2011,24(5):2841-2843.
[2]   李义 . 狂犬病的诊断与防治研究. 上海畜牧兽医通讯, 2018,23(4):56-57.
[2]   Li Y . Diagnosis and prevention of rabies. Shanghai Livestock and Veterinary Communication, 2018,23(4):56-57.
[3]   蔡黎, 朱政纲, 文丽 , 等. 人用狂犬病疫苗研究进展. 药物流行病学杂志, 2017,26(12):841-844.
[3]   Cai L, Zhu Z G, Wen L , et al. Progress in research on human rabies vaccine. Chinese Journal of Pharmacoepidemiology, 2017,26(12):841-844.
[4]   王春雨, 徐琳凯, 李超 , 等. 工艺处理过程中病毒的灭活效果研究. 实验动物科学, 2015,32(2):15-17.
[4]   Wang C Y, Xu L K, Li C , et al. Study on the inactivation effect of virus during process. Laboratory Animal Science, 2015,32(2):15-17.
[5]   国家药品监督管理局. 生物制品生产工艺过程变更管理技术指导原则.[ 2018-09-15]. http://www.sda.gov.cn/WS01/CL0844/9350.html.
[5]   State Drug Administration. Biological product production process change management techn-ology guiding principles.[ 2018-09-15]. http://www.sda.gov.cn/WS01/CL0844/9350.html.
[6]   宋清爽, 吴恩应, 张运佳 , 等. 血液制品病毒灭活及去除工艺进展. 生物技术通讯, 2012,23(4):627-630.
[6]   Song Q S, Wu E Y, Zhang Y J , et al. Advance in virus inactivation and removal processes of blood products. Letters In Biotechnology, 2012,23(4):627-630.
[7]   She Y M, Cheng K D, Aaron Farnsworth , et al. Surface modifications of influenza proteins upon virus inactivation by β-propiolactone. Proteomics, 2013,13(23):3537-3547.
doi: 10.1002/pmic.v13.23-24
[8]   Sasaki Y, Yoshino N, Sato S , et al. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus. Journal of Virological Methods, 2016,235(4):105-111.
doi: 10.1016/j.jviromet.2016.04.013
[9]   Chen W, Li Z, Liu J , et al. Application of β-propiolactone in HFRS vaccine. Chinese Journal of Public Health, 2003,19(6):669-670.
[10]   Zhang Y H, Gao C, Pan G , et al. Determination of β-propiolactone residues in human rabies vaccine for Vero cells. Chinese Journal of Biologicals, 1998,11(3):144.
[11]   杨健, 高军, 张庆义 , 等. β-丙内酯含量气相色谱检测方法的建立及其水解情况分析. 中国生物制品学杂志, 2010,23(3):323-324.
[11]   Yang J, Gao J, Zhang Q Y , et al. Development of gas chromatography for determination of Propiolactone(BPL)content and analysis of BPL hydrolysis. Chinese Journal of Biologicals, 2010,23(3):323-324.
[12]   梁婧, 李举, 马继华 , 等. 气相色谱法检测灭活狂犬病病毒浓缩液中β-丙内酯的含量. 中国生物制品学杂志, 2017,30(12):1317-1320.
[12]   Liang J, Li J, Ma J H , et al. Determination of β-propiolactone content in inactivated rabies virus concentrate by gas chromatography. Chinese Journal of Biologicals, 2017,30(12):1317-1320.
[13]   Shan G Z, Ma X, Ji H , et al. Determination of residual β-propiolactone in inactivated rabies virus concentrate by gas chromatography. China Pharmacy, 2014,25(25):2357-2359.
[14]   Xu Y, Wei R, Jiang Y , et al. Study on the determination of β-propiolactone in rotavirus vaccine by gas chromatography. Progress in Microbiology and Immunology, 2010,38(4):21-23.
[15]   Lei S, Gao X, Sun Y , et al. Gas chromatography-mass spectrometry method for determination of β-propiolactone in human inactivated rabies vaccine and its hydrolysis analysis. Journal of Pharmaceutical Analysis, 2018,6(3):373-377.
[16]   刘兆文, 李福安, 钱浩 . β-丙内酯在人用纯化地鼠肾细胞狂犬疫苗制备中的应用研究. 中国人兽共患病杂志, 1999,15(6):71-72.
[16]   Liu Z W, Li F A, Qian H . Study for application of β-propiolactone on preparation of human rabies vaccine of purified humster kidney cell. Chinese Journal of Zoonoses, 1999,15(6):71-72.
[17]   李福安, 窦志勇, 潘丽静 . 狂犬疫苗灭活后β-丙内酯水解的最佳pH值的选择. 中国公共卫生, 1999,15(11):964.
[17]   Li F A, Dou Z Y, Pan L J . Selection of optimal pH for hydrolysis of β-propiolactone after rabies vaccine inactivation. Chinese Journal of Public Health Management, 1999,15(11):964.
[18]   徐守振, 王新, 尹燕博 . 四种不同灭活剂对新城疫病毒的灭活效果研究. 中国家禽, 2011,33(14):15-19.
[18]   Xu S Z, Wang X, Yin Y B . Inactivation efficacy of newcastle disease virus with four different inactivants. China Poultry, 2011,33(14):15-19.
[19]   Delrue I, Verzele D, Madder A , et al. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev Vaccines, 2012,11(6):695-719.
doi: 10.1586/erv.12.38
[20]   龚文波, 郝伟伟, 廖韦萍 , 等. 两种不同灭活剂对基因Ⅶ型新城疫病毒灭活效果的影响研究. 四川畜牧兽医, 2017,44(10):21-23.
[20]   Gong W B, Hao W W, Liao W P , et al. Inactivation effect of genotype Ⅶ newcastle disease virus with two different inactivants. Sichuan Animal and Veterinary Sciences, 2017,44(10):21-23.
[21]   冯若飞, 樊得英, 韦鹏建 , 等. β-丙内酯对脑心肌炎病毒灭活效果的试验. 中国兽医杂志, 2011,47(8):19-21.
[21]   Feng R F, Fan D Y, Wei P J , et al. Experiment on the inactivation effect of β-propiolactone on encephalomyocarditis virus. Chinese Journal of Veterinary Medicine, 2011,47(8):19-21.
[22]   姜立民, 林晓波, 高磊 , 等. β-丙内酯对狂犬病病毒的灭活效果. 国际流行病学传染病学杂志, 2014,41(2):137-139.
[22]   Jing L M, Lin X B, Gao L , et al. Inactivation of rabies virus with β-propiolactone. Journal of the Chinese Medical Association, 2014,41(2):137-139.
[23]   国家药典委员会. 中国药典. 第三部. 北京: 中国医药科技出版社, 2015: 146-149.
[23]   Chinese Pharmacopoeia Commission. Chinese pharmacopoeia. Third part. Beijing: China Medical Science and Technology Press, 2015: 146-149.
[1] ZHAO Hui, ZHENG Wen-ling, PENG Yi-fei, MA Wen-li. Protection Effect of Recombinant Oral Rabies Vaccine for Human Use on Immunity of Mice[J]. China Biotechnology, 2014, 34(1): 9-14.